Eikon Therapeutics is planning to…
Eikon Therapeutics is planning to become the second biotech to [...]
Eikon Therapeutics is planning to become the second biotech to [...]
The new year has ushered in a flow of biotech-specific [...]
AirNexis Therapeutics is taking flight with $200 million and a [...]
Madrigal paid Pfizer $50 million for the rights to a [...]
Menlo Ventures has made a $16 million bet that the [...]
Roche has got in on the B7-H3 action, agreeing to [...]
Aktis Oncology exceeded its own expectations for its IPO in [...]
After netting a $361 million series C funding round in [...]
After unsheathing just a few months ago, Ollin Biosciences’ next-gen [...]
GSK has committed $50 million in upfront capital and near-term [...]